BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18215174)

  • 1. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
    Gallen IW; Jaap A; Roland JM; Chirayath HH
    Diabet Med; 2008 Feb; 25(2):165-9. PubMed ID: 18215174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of insulin glargine during pregnancy: a case-control pilot study.
    Price N; Bartlett C; Gillmer M
    BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes.
    Lepercq J; Jacqueminet S; Hieronimus S; Timsit J; Grimaldi A
    Diabetes Metab; 2010 Jun; 36(3):209-12. PubMed ID: 20188617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
    Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of glargine use in pregnancy.
    Henderson CE; Machupalli S; Marcano-Vasquez H; Kerr P; Reilly KD
    J Reprod Med; 2009 Apr; 54(4):208-10. PubMed ID: 19438161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnant women with type 1 diabetes mellitus treated by glargine insulin.
    Al-Shaikh AA
    Saudi Med J; 2006 Apr; 27(4):563-5. PubMed ID: 16598316
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
    Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
    Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979-95.
    Silva Idos S; Higgins C; Swerdlow AJ; Laing SP; Slater SD; Pearson DW; Morris AD
    Diabet Med; 2005 Apr; 22(4):440-7. PubMed ID: 15787670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women.
    Torlone E; Gennarini A; Ricci NB; Bolli GB
    Eur J Obstet Gynecol Reprod Biol; 2007 Jun; 132(2):238-9. PubMed ID: 16806646
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
    Lapolla A; Dalfrà MG; Fedele D
    Diabetes Metab Res Rev; 2005; 21(3):241-52. PubMed ID: 15818714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).
    Masson EA; Patmore JE; Brash PD; Baxter M; Caldwell G; Gallen IW; Price PA; Vice PA; Walker JD; Lindow SW
    Diabet Med; 2003 Jan; 20(1):46-50. PubMed ID: 12519319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome.
    Callesen NF; Damm J; Mathiesen JM; Ringholm L; Damm P; Mathiesen ER
    J Matern Fetal Neonatal Med; 2013 Apr; 26(6):588-92. PubMed ID: 23211128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of insulin glargine during pregnancy.
    Pöyhönen-Alho M; Rönnemaa T; Saltevo J; Ekblad U; Kaaja RJ
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1171-4. PubMed ID: 17851816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glargine in pregnant patients with Type 1 diabetes.
    Tahrani AA; Varughese GI; Wilkins JD; Taylor SE; Hanna FW
    Diabet Med; 2008 Jan; 25(1):111-2. PubMed ID: 18199139
    [No Abstract]   [Full Text] [Related]  

  • 18. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents.
    Ekpebegh CO; Coetzee EJ; van der Merwe L; Levitt NS
    Diabet Med; 2007 Mar; 24(3):253-8. PubMed ID: 17305787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified management of diabetic pregnant woman.
    Mirghani OA; Saeed OK
    Saudi Med J; 2000 Apr; 21(4):335-9. PubMed ID: 11533813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.